参考文献/References:
[1]Mathiowetz AJ,Olzmann JA. Lipid droplets and cellular lipid flux[J]. Nat Cell Biol,2024,26(3):331-345.?div>[2]Wan N,Hong Z,Parson MAH,et al. Spartin-mediated lipid transfer facilitates lipid droplet turnover[J]. Proc Natl Acad Sci U S A,2024,121(3):e2314093121.?/div>[3]Corbo JH,Chung J. Mechanisms of lipid droplet degradation[J]. Curr Opin Cell Biol,2024,90:102402.?/div>
[4]Dian YT,Yang Y,Zhu P,et al. [Lipid droplets and perilipins in cardiovascular diseases][J]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2022,44(3):463-471.
[5]Thiele C,Spandl J. Cell biology of lipid droplets[J]. Curr Opin Cell Biol,2008,20(4):378-385.?/div>
[6]O’Connor FK,Sabapathy S,Sharma P,et al. Acute lower-limb heating improves exercise performance in heart failure with reduced ejection fraction[J]. Eur J Heart Fail,2025,27(5):1123-1132.?/div>
[7]Eichelmann F,Prada M,Sellem L,et al. Lipidome changes due to improved dietary fat quality inform cardiometabolic risk reduction and precision nutrition[J].?at Med,2024,30(10):2867-2877.?/div>
[8]Kumari RM,Khatri A,Chaudhary R,et al. Concept of lipid droplet biogenesis[J].?ur J Cell Biol,2023,102(4):151362.?/div>
[9]Martin S,Parton RG. Lipid droplets:a unified view of a dynamic organelle[J].?at Rev Mol Cell Biol,2006,7(5):373-378.?/div>
[10]Tang L,Hu D,Feng J,et al. Liquid core fluorescent organic nanoprobes:long-term stability and highly selective lipid droplets bio-imaging[J]. Talanta,2024,267:125169.?/div>
[11]Gluchowski NL,Becuwe M,Walther TC,et al. Lipid droplets and liver disease:from basic biology to clinical implications[J].?at Rev Gastroenterol Hepatol,2017,14(6):343-355.?/div>
[12]Enkler L,Spang A. Functional interplay of lipid droplets and mitochondria[J].?EBS Lett,2024,598(10):1235-1251.?/div>
[13]秦颐雪,金磷璐,曾烨. 糖萼介导的低层流剪切力诱导血管内皮细胞泡沫化[J]. 医用生物力学,2024,39(S01):363-369。
[14]Ahmed ME,Leistner DM,Hakim D,et al. Endothelial shear stress metrics associate with proinflammatory pathways at the culprit site of coronary erosion[J].?ACC Basic Transl Sci,2024,9(11):1269-1283.?/div>
[15]Chen B,Shi Y,Zhang K,et al. Inulin reduces liver triacylglycerol by increasing lipid droplet lipolysis in fat-loaded mice[J].?ood Res Int,2023,163:112226.?/div>
[16] Zhou R,Wang Y,Chen S,et al. Anti-Inflammatory effect of?endrobium officinale?xtract on high-fat diet-induced obesity in rats:involvement of gut microbiota,liver transcriptomics,and NF-κB/IκB Pathway[J]. Antioxidants (Basel),2025,4(4):432.
[17]Perman JC,Bostr? P,Lindbom M,et al. The VLDL receptor promotes lipotoxicity and increases mortality in mice following an acute myocardial infarction[J].? Clin Invest,2011,121(7):2625-2640.?/div>
[18]Cho KY,Miyoshi H,Nakamura A,et al. Lipid droplet protein PLIN1 regulates inflammatory polarity in human macrophages and is involved in atherosclerotic plaque development by promoting stable lipid storage[J].? Atheroscler Thromb,2023,30(2):170-181.?/div>
[19]Todosenko N,Yurova K,Khaziakhmatova O,et al. The Role of (nuclear) lipid droplets in the pathogenesis of metabolic syndrome[J].?ront Biosci (Landmark Ed),2025,30(6):26742.?/div>
[20]Hayward GC,Fenech RK,Yang AJ,et al. The role of PLIN protein in healthy lipid storage and lipid droplet expansion[J].? Physiol,2017,595(24):7273-7274.?/div>
[21]Yoon H,Shaw JL,Haigis MC,et al. Lipid metabolism in sickness and in health:Emerging regulators of lipotoxicity[J].?ol Cell,2021,81(18):3708-3730.?/div>
[22]浦冬青,刘政,周超,等. 近10年动脉粥样硬化发病机制研究热点的可视化分析[J]. 世界科学技术(中医药现代化),2021,23(7):2276-2284。
[23]Bookmeyer CHM,Correig Blanchar FX,Masana L,et al. Advancing atherosclerosis research:the power of lipid imaging with MALDI-MSI[J]. Atherosclerosis,2025,403:119130.?/div>
[24]Tan YJ,Huang ZZ,Jin Y,et al. Lipid droplets sequester palmitic acid to disrupt endothelial ciliation and exacerbate atherosclerosis in male mice[J]. Nat Commun,2024,15(1):1-19.
[25]Boutagy NE,Gamez-Mendez A,Fowler JW,et al. Dynamic metabolism of endothelial triglycerides protects against atherosclerosis in mice[J].? Clin Invest,2024,134(4):e170453.?/div>
[26]Liu QN,Zhao XH,Li S,et al. Plin2 involved in oxLDL-induced LOX1 expression in macrophages via NF-κB pathway[J]. Prog Biochem Biophys,2023,50(11):2697-2708.
[27]You YZ,Liang W. SIRT1 and SIRT6:the role in aging-related diseases[J]. Biochim Biophys Acta Mol Basis Dis,2023,1869(7):166815.
[28]Wang T,Cheng Z,Zhao R,et al. Sirt6 enhances macrophage lipophagy and improves lipid metabolism disorder by regulating the Wnt1/β-catenin pathway in atherosclerosis[J]. Lipids Health Dis,2023,22(1):156.?/div>
[29]Ghafoor A. Turning heart failure into heart success[J]. Heart Fail Clin,2024,20(4):xi-xii.?/div>
[30]Khandait H,Sodhi SS,Khandekar N,et al. Cardiorenal syndrome in heart failure with preserved ejection fraction:insights into pathophysiology and recent advances[J]. Cardiorenal Med,2025,15(1):41-60.
[31]D’Amato A,Prosperi S,Severino P,et al. Current approaches to worsening heart failure:pathophysiological and molecular insights[J]. Int J Mol Sci,2024,25(3):1574.?/div>
[32]Holzem KM,Vinnakota KC,Ravikumar VK,et al. Mitochondrial structure and function are not different between nonfailing donor and end-stage failing human hearts[J]. FASEB J,2016,30(8):2698-2707.?/div>
[33]Tan W,Wang Y,Cheng S,et al. AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis[J]. J Adv Res,2025,68:299-315.?/div>
[34]Sera AC,Bui TA,Oceandy D. Expression of pontin (RUVBL1) reduces lipid accumulation and improves survival of cardiomyoblast cells following stimulation with saturated fatty acid[J]. Heart,2024,110(3):279-286.
[35]Li LH,Zhang HN,Wang WY,et al. Comparative proteomics reveals abnormal binding of ATGL and dysferlin on lipid droplets from pressure overload-induced dysfunctional rat hearts[J]. Sci Rep,2016,6:19782.
[36]Kantharia BK,Zhao S,Linz D,et al. Hypertension and atrial fibrillation:insight from basic to translational science into the mechanisms and management[J]. J Cardiovasc Electrophysiol,2025,36(10):2712-2719.?/div>
[37]杨红霞,景策,刘睿,等. 高血压发病机制研究进展[J]. 医学综述,2019,25 (22):4483-4487.
[38]Kim B,Zhao W,Tang SY,et al. Endothelial lipid droplets suppress eNOS to link high fat consumption to blood pressure elevation[J]. J Clin Invest,2023,133(24):e173160.?/div>
[39]Swiatlowska P,Tipping W,Marhuenda E,et al. Hypertensive pressure mechanosensing alone triggers lipid droplet accumulation and transdifferentiation of vascular smooth muscle cells to foam cells[J].?dv Sci (Weinh),2024,11(9):e2308686.
[40]刘旋,赵福森,徐启耀,等. 基于管周脂肪炎性微环境的黄芩汤调控NEK7-NLRP3/IL-1β保护肥胖高血压大鼠血管内皮功能研究[J]. 南京中医药大学学报,2024,40(9):896-905.
[41]Li Y,Zhou E,Yu Y,et al. Butyrate attenuates cold-induced hypertension via gut microbiota and activation of brown adipose tissue[J].?ci Total Environ,2024,943:173835.
[42]Eleid MF,Nkomo VT,Pislaru SV,et al. Valvular heart disease:new concepts in pathophysiology and therapeutic approaches[J].?nnu Rev Med,2023,74:155-170.?/div>
[43]Zhuang W,Li J,Qu T,et al. A lipid activated color switchable probe for the imaging of diseased aortic valves[J].?alanta,2024,275:126069.?/div>
[44]潘路华,朱明利,陈多学,等. 血清脂蛋白a水平与二尖瓣环钙化的相关性分析[J]. 中华全科医学,2024,22(10):1700-1704.
[45]Golledge J,Thanigaimani S,Powell JT,et al. Pathogenesis and management of abdominal aortic aneurysm[J].?ur Heart J,2023,44(29):2682-2697.?/div>
[46]田丽,张瑾瑾,张娜娜,等. 二甲双胍通过抑制缺氧诱导脂滴相关蛋白与卷曲蛋白10相互作用及其下游Wnt信号减缓腹主动脉瘤形成的研究[J].中国糖尿病杂志,2022,30(2):120-125.
[47]Ray L,Geier C,DeWitt KM. Pathophysiology and treatment of adults with arrhythmias in the emergency department,part 1:atrial arrhythmias[J].?m J Health Syst Pharm,2023,80(16):1039-1055.?/div>
[48]Morrissette-McAlmon J,Xu WR,Teuben R,et al. Adipocyte-mediated electrophysiological remodeling of human stem cell-derived cardiomyocytes[J].? Mol Cell Cardiol,2024,189:52-65.?/div>
[49]Filipski KJ,Edmonds DJ,Garnsey MR,et al. Design of next-generation DGAT2 inhibitor PF-07202954 with longer predicted half-life[J].?CS Med Chem Lett,2023,14(10):1427-1433.?/div>
[50]Sun Q,Xing X,Wang H,et al. SCD1 is the critical signaling hub to mediate metabolic diseases:mechanism and the development of its inhibitors[J].?iomed Pharmacother,2024,170:115586.?/div>
[51]Haemmerle G,Moustafa T,Woelkart G,et al. ATGL-mediated fat catabolism regulates cardiac mitochondrial function via PPAR-α and PGC-1[J].?at Med,2011,17(9):1076-1085.?/div>
[52]Kopietz F,Alshuweishi Y,Bijland S,et al. A-769662 inhibits adipocyte glucose uptake in an AMPK-independent manner[J].?iochem J,2021,478(3):633-646.?/div>
[53]Zhang C,Deng J,Liu D,et al. Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway[J].?r J Pharmacol,2018,175(22):4218-4228.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(12):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(12):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(12):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(12):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(12):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(12):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
[11]李甜甜 亓秉超 陈亮 李妍.以线粒体为中心的调控网络在心血管疾病中的研究进展[J].心血管病学进展,2024,(4):350.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.014]
LI Tiantian,QI Bingchao,CHEN Liang,et al.Mitochondria-Centered Regulatory Network in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2024,(12):350.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.014]
[12]蒲思颖 胡朗 郭艳杰 李妍.脂滴与细胞器之间的相互作用在心血管疾病中的研究进展[J].心血管病学进展,2025,(1):37.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.009]
PU Siying,HU Lang,GUO Yanjie,et al.The Interaction Between Lipid Droplets and Organelles in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2025,(12):37.[doi:10.16806/j.cnki.issn.1004-3934.2025.01.009]